Technique for the prevention of false positive reactions in immunological testing due to C.sub.1 and C.sub.1q components of the complement and method for screening for rheumatic factor
AssigneeMontefiore Medical Center
InventorJacques Singer
Life of this patent
Estimating the term…
Abstract
A novel technique is disclosed for the prevention of false positive reactions in immunological testing which are caused by interference of C.sub.1 and C.sub.1q. The method is based on heating a sample of a body fluid at a temperature of 59.degree.-64.degree. C. in the presence of a particular neutral salt. A method for screening for rheumatoid factor is also disclosed.
Claims12
A method for preventing interference caused by C.sub.1 or C.sub.1q in an immunoassay of a body fluid for an antigen or an antibody, said method comprising heating a sample of said body fluid, which is diluted sufficiently to permit an immunoassay, to a temperature of 59.degree. C. to 64.degree. C. with a neutral salt for a period of time sufficient for said neutral salt to prevent said interference caused by said C.sub.1 or C.sub.1q without affecting said antigen or said antibody in said immunoassay.
A method for preventing increased formation of aggregates of immunoglobulin in a body fluid while inactivating C.sub.1q in said body fluid, said method comprising heating a sample of said body fluid, which is sufficiently diluted to permit an immunoassay, to a temperature of 59.degree. C. to 64.degree. C. with a neutral salt for a period of time to inactivate said C.sub.1q without causing said increased formation of said aggregates of said immunoglobulin.
A method for detecting rheumatoid factor (RF) in a body fluid comprising immunoreactive antigens and antibodies, said method comprising:
- (a) diluting a first aliquot of a body fluid 1:10 with a pH 8.2 glycine buffer and contacting thereto a first suspension of uncoated latex particles, wherein a lack of flocculation after three minutes indicates the absence of said RF,
- (b) if said (a) results in flocculation,
- (1) heating a second aliquot of said body fluid diluted 1:10 with said pH 8.2 glycine buffer to a temperature of 59.degree. C. to 64.degree. C. with a neutral salt for 3 to 30 minutes such that said neutral salt inactivates any C.sub.1q present in said body fluid without affecting the immunoreactivity of said antigens or said antibodies to form a heat treated sample, and
- (2) contacting said heat treated sample with a suspension of said uncoated latex particles, wherein any resultant flocculation indicates the presence of RF in said body fluid.
A method for preventing interference caused by C.sub.1 or C.sup.1q in a latex particle photometric immunoassay of a body fluid for an antigen or an antibody, said method comprising heating a sample of said body fluid, which is diluted sufficiently to permit an immunoassay, to a temperature of 59.degree. C. to 64.degree. C. with a neutral salt for a period of time sufficient for said neutral salt to prevent said interference caused by said C.sub.1 or C.sub.1q without affecting said antigen or said antibody in said latex particle photometric immunoassay.
Dependencies are inferred from the claim text.